Oral levofloxacin 600 mg and 300 mg daily doses in difficult-to-treat respiratory infections.
Shishido
H
H
Department of Respiratory Diseases, Tokyo National Chest Hospital, Japan.
Furukawa
K
K
Nagai
H
H
Kawakami
K
K
Kono
H
H
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D064704:Levofloxacin; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D000890:Anti-Infective Agents; D064704:Levofloxacin; D015242:Ofloxacin